Medical Centre Valuation Mandate in a Strategic Partnership Context
Independent valuation of a multidisciplinary medical centre conducted to support a strategic partnership and merger discussions
Description of the mandate: valuation of a Swiss multidisciplinary medical centre for a strategic partnership
The engagement focused on the determination of the fair economic value of a company operating a multidisciplinary medical centre dedicated to musculoskeletal care. The business valuation was conducted in the context of a strategic partnership aimed at strengthening cooperation between two facilities through the sharing of medical resources, the pooling of management, and improved territorial coverage.
The role assigned — that of an independent arbiter mandated by the acquirer — required a precise understanding of the operating model of a private medical centre in French-speaking Switzerland and a rigorous methodological framework compliant with Swiss and international valuation standards.
Key challenges: objectifying the value of a human-intensive medical service
The main challenges of the mandate were:
- determining the fair value of a medical centre based on human expertise;
- assessing the sustainability of revenue streams linked to the patient base and medical partnerships;
- measuring the organisational and financial impact of the partnership (synergies, pooling, quality of care);
- ensuring an impartial value arbitration between the two medical directorates.
Approach and outcomes: cross-checking DCF with synergies, capitalised earnings, multiples, substantial value and practitioners' method
The valuation deployed a set of complementary financial approaches adapted to medical services:
- the capitalised earnings method, based on the capitalisation of normalised average earning capacity;
- the discounted cash flow (DCF) method, incorporating management synergies, pooling effects and post-merger growth prospects;
- the market multiples method, based on a sample of comparable medical centres in Switzerland and Europe (EV/EBITDA multiples typically between 7.0x and 11.0x);
- the trading multiples method, applied to listed healthcare players to establish a sector reference;
- the substantial value method, identifying the net asset value of fixed assets and medical investments;
- the practitioners' method — the Swiss reference — combining the capitalised earnings value and the substantial value.
The cross-checking analysis enabled a coherent strategic value range to be identified, incorporating current economic parameters and medium-term value-creation levers. The mandate helped objectify discussions between the parties, reconciling financial, medical and human considerations.
Illustrative example: numerical application to a multidisciplinary medical centre
For illustrative purposes only — unrelated to the actual data of the mandate — a medical centre generating CHF 6M in revenue with an EBITDA of CHF 1.2M (20% margin) could exhibit an enterprise value range of between CHF 8.4M and 13.2M based on sector multiples of 7.0x to 11.0x EBITDA. With the integration of synergies (back-office pooling, consumables purchasing, common technical platform) estimated at CHF 200-400k on a recurring basis, the DCF tightens the range towards a defensible median, with the practitioners' method providing the final convergence.
Summary: 5-week mandate, six cross-checked methods, independent arbitration between medical directorates
Business valuation mandate delivered in 5 weeks for a Swiss medical centre in a strategic partnership. Six methods deployed (capitalised earnings, DCF, transaction multiples, trading multiples, substantial value, practitioners). Deliverable: independent report enabling the objectification of discussions between the two directorates and validation of a consensual value range.
Frequently asked questions: medical centre valuation, synergies and Swiss standards
What EBITDA multiples for a medical centre in Switzerland?
Based on recent transactions in Switzerland and Europe, EV/EBITDA multiples stand between 7.0x and 11.0x for multidisciplinary medical centres, with a significant premium for facilities with differentiating technical platforms (imaging, surgical robotics) and a loyal patient base. Trading multiples (Mediclinic, Hirslanden, Médipôle) provide a complementary reference.
How to integrate synergies into a merger DCF?
Synergies are integrated into the DCF via a dedicated module distinguishing (i) cost synergies (back-office pooling, purchasing), (ii) revenue synergies (cross-selling specialties, common platform), (iii) integration costs (one-off). The report must present (i) the standalone DCF, (ii) the DCF with synergies, (iii) the valued differential.
Why use the practitioners' method in Switzerland?
The practitioners' method is the Swiss reference for non-listed companies: a weighted average of the capitalised earnings value (often 2x) and the substantial value (often 1x). It reflects both recurring earning capacity and the company's economic substance.
How long does a valuation for a medical merger take?
The standard duration is 4 to 7 weeks, depending on the availability of restated financial data, historical depth, and accessibility of operational information (active patient file, specialty mix, occupancy rate). The mandate described was completed in 5 weeks.
How to treat the intangible assets of a medical centre?
The intangible assets of a medical centre (reputation, patient loyalty, physician partnerships) are integrated via (i) the DCF which captures the value generated by these assets, (ii) the differential between the capitalised earnings method and the substantial value (proxy of goodwill), (iii) an explicit reading in the report identifying differentiating factors.
Is the report usable in case the merger fails?
Yes. An independent valuation report retains its full methodological value outside the initial context: it can be reused for other transactions (transfer, fundraising, shareholder arbitration), or updated through a targeted review of key assumptions. To go further: when to call an independent expert.
Similar mandates: other business valuations in healthcare
The transactions shown include those completed by, or with the involvement of, Hectelion team members in current or previous professional roles. They are presented for illustrative purposes only and do not imply exclusive responsibility by Hectelion.
Discover our TRACK RECORD
The transactions presented were carried out by, with the contribution of, or with the participation of members of the Hectelion team in the context of functions performed currently or previously.